Table 2.
KEGG pathway enrichment analysis of the SARGs and OMRGs (the top pathway terms).
| DEGs | Pathway ID | Name | Count | % | P-value |
|---|---|---|---|---|---|
| SARGs | hsa04380 | Osteoclast differentiation | 10 | 4.76 | 3.22E-05 |
| hsa04640 | Hematopoietic cell lineage | 8 | 3.81 | 8.14E-05 | |
| hsa05202 | Transcriptional misregulation in cancer | 8 | 3.81 | 0.004749631 | |
| hsa04610 | Complement and coagulation cascades | 6 | 2.86 | 0.001597673 | |
| hsa04612 | Antigen processing and presentation | 6 | 2.86 | 0.002453934 | |
| hsa04664 | Fc epsilon RI signaling pathway | 5 | 2.38 | 0.009949792 | |
| hsa05150 | Staphylococcus aureus infection | 4 | 1.9 | 0.029278407 | |
| hsa05134 | Legionellosis | 4 | 1.9 | 0.029278407 | |
| OMRGs | hsa05034 | Alcoholism | 10 | 2.66 | 0.005412177 |
| hsa05322 | Systemic lupus erythematosus | 9 | 2.39 | 0.00329809 | |
| hsa05205 | Proteoglycans in cancer | 9 | 2.39 | 0.031838957 | |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 5 | 1.33 | 0.042148285 |